AIM
TEVA icon

Anchor Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Anchor Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-232
Closed -$2.24K – 1001
2020
Q4 		$2.24K Buy
+232
New +$2.22K ﹤0.01% 836
2019
Q2 		– Sell
-1,750
Closed -$27.4K – 823
2019
Q1 		$27.4K Sell
1,750
-800
-31% -$14.1K 0.01% 524
2018
Q4 		$39.3K Sell
2,550
-50
-2% -$1.02K 0.01% 468
2018
Q3 		$56K Sell
2,600
-400
-13% -$9.29K 0.01% 462
2018
Q2 		$73K Hold
3,000
– – 0.02% 433
2018
Q1 		$51.3K Sell
3,000
-3,069
-51% -$59.9K 0.01% 471
2017
Q4 		$115K Sell
6,069
-13,730
-69% -$207K 0.03% 355
2017
Q3 		$348K Sell
19,799
-5,600
-22% -$126K 0.1% 206
2017
Q2 		$844K Buy
25,399
+500
+2% +$15.5K 0.28% 91
2017
Q1 		$799K Sell
24,899
-1,350
-5% -$46.1K 0.27% 92
2016
Q4 		$952K Sell
26,249
-2,370
-8% -$94.6K 0.36% 77
2016
Q3 		$1.32M Sell
28,619
-1,655
-5% -$86.3K 0.51% 56
2016
Q2 		$1.52M Sell
30,274
-200
-0.7% -$10.6K 0.6% 47
2016
Q1 		$1.63M Buy
+30,474
New +$1.79M 0.67% 41

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Anchor Investment Management's TEVA Position: Q1 2021 in Review

Anchor Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2021, closing a stake of 232 shares — an estimated $2.24K sold.

Anchor Investment Management first reported a position in TEVA in Q1 2016 and held it in 14 quarters. The position peaked at $1.63M in Q1 2016. 451 funds tracked by Wall St. Rank hold TEVA as of Q1 2021.

  • Anchor Investment Management reported no remaining Teva Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Anchor Investment Management sold 232 Teva Pharmaceuticals shares in Q1 2021, an estimated $2.24K.
  • Anchor Investment Management first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 14 quarters.
  • Anchor Investment Management's Teva Pharmaceuticals position peaked at $1.63M in Q1 2016.
  • 451 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2021.

Based on Anchor Investment Management's 13F filing for Q1 2021, filed 2 Jan 2024.